Psychoactive substances are some of the ingredients used in different drugs that affect the mind. You might know such drugs as party pills, herbal highs, legal highs, synthetic cannabis or legal recreational drugs.
Important information for retailers
By the end of 2015 it is expected that the Psychoactive Substances Regulations 2014 will be amended to allow licences to sell approved products by retail to be applied for and issued. You can download a copy of the regulations from www.legislation.govt.nz.
Licence applications cost $12,000 in addition to the $7,000 annual levy. Licences can only be issued for a maximum of three years at a time.
Note: There are currently no approved products.
Due to the prohibition on the use of animal testing for the purposes of assessing whether a psychoactive product should be approved, it is unlikely that there will be any approved products for at least the next three years. On this basis, the Authority recommends that you do not apply for a licence to sell psychoactive substances by retail at this time.
If you still choose to apply for a licence, you can download an application form from the “Guidelines and application forms” link under “Quick links”.
Prospective retail sites must comply with the local approved products policy (LAPP) put in place by the territorial authority (city or district council) in which the site is located. You can find a list of territorial authorities and a link to their LAPPs under the “Guidelines and application forms” link under “Quick links”. You should check and make sure your retail site complies with the relevant LAPP before applying for a licence because application fees are unlikely to be refunded for failing to meet the LAPP.
For more information on licences to sell approved products by retail please refer to the Psychoactive Substances Guide to the Licensing Scheme which can be downloaded from the “Guidelines and application forms” link under “Quick links”.
News and Events
|05/06/2015||News item||Psychoactive Substances Retail Regulations|
|26/05/2015||Media release||Minister concerned at reports of adverse reactions|
|01/05/2015||Update||No applications for product approvals have been received.|
|20/03/2015||Voluntary recall||Products containing 1,3-dimethylbutylamine (DMBA).|